USPTO serial 77713080
EPIGENOMICALS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- TRUSILO, KELLY JEAN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EPIGENOMICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New York, NY
New York, NY
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Antioxidants and proteins used in the manufacture of cosmetics, beverages, food products and food supplements; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Chemical additives for use as cleansing, deodorizing and refreshing ingredients in the manufacture of mouth sprays, dental cements and medicines for dental purposes; Chemical additives for use in the manufacture of pharmaceuticals, nutraceuticals, supplements; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Food supplements for agricultural products and other plants; Perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals | ACTIVE | — |
| 005 | Animal feed supplements; Anti-diabetic pharmaceuticals; Antiallergic medicines; Antibacterial pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Astringents; Astringents for medicinal purposes; Biometallic compounds being a component in pharmaceutical preparations for cancer, diabetes, cardiovascular disease, autoimmune disease, neurodegenerative disease; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Dietary and nutritional supplements; Dietary and nutritionally fortified food products adapted for medical use; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietary supplements for animals; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Dietary supplements for pets; Dietetic foods adapted for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for compounds and colloids that facilitate the delivery of a wide range of pharmaceuticals; Feed supplements for animals; Food for medically restricted diets; Food supplements; Food supplements, namely, anti-oxidants; Foods for individuals with special dietary requirements necessitated by medical treatments; Foods for medical purposes that help in the treatment of thrombolysis; Freeze-dried food bait to attract flies for pest control purposes; Gelatin capsules sold empty for pharmaceuticals; Ginseng for medicinal use; Ground flaxseed fiber for use as a dietary supplement; Herb teas for medicinal purposes; Herbal supplements; Herbs for medicinal purposes; Homeopathic pharmaceuticals for use in the treatment of cancer, diabetes, neurodegenerative diseases; Homeopathic supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with pharmaceuticals, nutraceuticals, supplements; Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Liquid nutritional supplement; Meal replacement and dietary supplement drink mixes; Medicinal creams for skin care; Medicinal drinks; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal preparations for stimulating hair growth; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal tea; Medicines for the treatment of gastrointestinal diseases; Mineral food supplements; Mineral nutritional supplements; Natural dietary supplements for treatment of claustrophobia; Natural herbal supplements; Natural supplements for treating candida; Natural supplements for treating depression and anxiety; Natural supplements for treating erectile dysfunction; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for the treatment of cancer, diabetes, cardiovascular disease, auto-immune disease, glycemic control, neurodegenerative disease; Nutraceuticals for use as a dietary supplement; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional oils not for food or cosmetic purposes; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplements; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of cancer, diabetes, cardio-vascular disease, glycemic control, auto-immune disease, neurodegenerative disease; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of cancer, diabetes, cardio-vascular disease, glycemic control, neurodegenerative disease; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Powdered fruit-flavored dietary supplement drink mix; Protein supplements; Therapeutic pharmaceutical for the treatment of cancer, diabetes, glycemic control, cardio-vascular disease, auto-immune disease, neurodegenerative disease; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Vitamin and mineral supplements | ACTIVE | — |
| 010 | Drug delivery systems | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Etra, Aaron
- Other trademarks owned by Etra, Aaron
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named EPIGENOMICALS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 7, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 7, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 3, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 11, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 22, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 9, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 9, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jun 30, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 30, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 18, 2009 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Apr 17, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 17, 2009 | NWAP | NEW APPLICATION ENTERED | — |